Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat vs Polyglucosamine for Overweight and Obesity
NCT02529631Completed
- Sponsor
- Certmedica International GmbH
- Start
- Nov 2009
- Primary completion
- Jun 2010
- Countries
- 2
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Certmedica International GmbH. Primary endpoint: Number of participants with a weight reduction of >= 5 per cent at 12 weeks. Started Nov 2009; status: completed.
Beyond the preview
Go deeper on NCT02529631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02529631.